Supply data standards: Healthcare's enduring roller coaster ride

Dana Barlow, Rick
March 2016
Healthcare Purchasing News;Mar2016, Vol. 40 Issue 3, p10
Trade Publication
The article discusses the importance of supply data standards in the healthcare industry in the U.S. as of March 2016. Also cited are the evolution of electronic information systems and supply data standards since the 1970s, as well as the comments by industry experts like Greg Bylo of GS1 U.S. and Jay Crowley of USDM Life Sciences on the standards and other topics like the Unique Device Identification (UDI) regulations.


Related Articles

  • Avoiding those dark nights with detective work. Dana Barlow, Rick // Healthcare Purchasing News;Sep2012, Vol. 36 Issue 9, p58 

    The article discusses the challenges that hospitals face when managing product alerts and recalls linked to medical supplies and devices. A discussion of the U.S. Food and Drug Administration Act, which authorized the administration to electronically monitor the safety of regulated drugs,...

  • tying supply chain costs to patient care. Parkinson, Rosalind C. // hfm (Healthcare Financial Management);May2014, Vol. 68 Issue 5, p42 

    The article discusses the unique device identification (UDI) system that the U.S. Food and Drug Administration (FDA) will establish in September 2014 to help hospitals to track and manage medical devices and analyze their effectiveness. Topics covered include the link between supply cost and...

  • Accelerating change: Supply chain practices are ripe for improvement from innovation, automation. Rardin, Ron; Jayaraman, Raja // Modern Healthcare;7/25/2011 Anniversary Issue, p68 

    The article discusses the opportunities presented by innovation and automation for improved healthcare services in the U.S. in 2011. It says that bar-coding of GS1-labeled merchandise can help keep track of outdated material, avoid time lost to the misplacement of goods and improve routine...

  • FDA reform: Is it enough? Robeznieks, Andis // Modern Healthcare;2/5/2007, Vol. 37 Issue 6, p6 

    The article reports on the changes expected from the U.S. Food and Drug Administration (FDA) after it proposed a revamp that would give healthcare providers more timely information on drug and device safety. As a response to a critical report from the Institute of Medicine released in 2006, the...

  • ID software means less chance of identity theft.  // Hospital Access Management;Jun2010, Vol. 29 Issue 6, p71 

    The article presents information about the patient identification system, used by Bay Care Health System in Tampa, Florida. After receiving constant complaints from the patients regarding security of sensitive identifying information this system was implemented. The system integrates with...

  • PEOPLE & OPINIONS Worth Repeating.  // Healthcare Purchasing News;Jun2012, Vol. 36 Issue 6, p56 

    No abstract available.

  • Industry Lobbies to Weaken Medical Device Oversight. Wolfe, Sidney M. // Health Letter;Apr2012, Vol. 28 Issue 4, p1 

    The article focuses on the U.S. Congress' consideration for the reauthorization of the Medical Device User Fee Act (MDUFA) in which the Food and Drug Administration (FDA) is required to collect application fees from companies seeking clearance to market new medical devices.

  • Speeding up medical-device approval. Kiernan, Vincent // Laser Focus World;Jan98, Vol. 34 Issue 1, p67 

    Talks about the Food and Drug Administration Modernization Act of 1997 which revises the procedures and standards in approving medical devices. Debate over the legislation; Classification of medical devices; Launching of a pilot program to test the effectiveness of third-party experts; Attempts...

  • MDMA also no fan of FDA's class IIb proposal.  // Medical Device Daily;10/11/2010, Vol. 14 Issue 197, p9 

    The article considers the response of the Medical Device Manufacturer's Association's (MDMA) to the proposal of the U.S. Food and Drug Administration (FDA) to split the class II device category into two groups.

  • Medical-Device Use Fee Passes Senate, Becomes Law. Raflo, Brook // HomeCare Magazine;Nov2002, Vol. 25 Issue 11, p12 

    Reports on the passing of a legislation concerning the U.S. Food & Drug Administration review application of medical device manufacturers in the U.S. in October 2002. Definition of a small company under the new law; Scope of the law; Comments regarding the passage of the legislation.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics